OmniSpirant Therapeutics
PrivateLast Round
Seed
Jan 14, 2025
Total Funding Raised
$13.81M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
OmniSpirant Therapeutics is a biotechnology company developing a first-in-class regenerative gene therapy platform, 'OmniSomes', for RNA-based treatments targeting respiratory diseases and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OmniSpirant Therapeutics Comparables
Compare OmniSpirant Therapeutics with similar companies based on industry and business-model similarity.
OmniSpirant Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 14, 2025 | ||||
| Grant | Feb 14, 2023 | ||||
| Grant | Jun 1, 2022 | ||||
| Grant | Feb 1, 2019 |
OmniSpirant Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| Emily's Entourage | Grant |
| Horizon Europe | Grant |
| Cystic Fibrosis Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2026
Grew 30% QoQ from 10 to 13 employees.
- May 1, 2025
Monthly visitors increased 1258% MoM, from 19 to 258.
OmniSpirant Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OmniSpirant Therapeutics's valuation, stock price, and market status.